Challenge Virus |
Vaccine platform |
Test Species |
References |
VEEV |
Adenovirus |
Mice (BALB/c) |
[65,66,68,85] |
Equine Herpesvirus
type I |
Mice (NIH Swiss) |
[71] |
Vaccinia virus |
Mice (NIH Swiss,
A/J, C3H, BALB/c) |
[77-80] |
DNA |
Mice (BALB/c), rabbit,
NHP |
[81-85] |
SINV/VEEV Chimeras |
Mice (NIH Swiss),
Hamster |
[31,32] |
VRP |
Mice (BALB/c), NHP |
P Glass, D Reed,
manuscript in
preparation |
Attenuated (furin
cleavage site
mutant) |
Mice (BALB/c, CH3,
C57BL/6, CD-1),
hamster, Horse, NHP |
[42-48] |
Attenuated and
Inactivated |
Mice (BALB/c, CD-1) |
[49-52] |
Subunit |
Mice (BALB/c, NIH
Swiss) |
[89,90] |
WEEV |
Adenovirus |
Mice (BALB/c) |
[16,69,70] |
SINV/WEEV Chimera |
Mice (NIH Swiss) |
[33,34] |
DNA |
Mice (BALB/c) |
[15,86] |
Attenuated (furin
cleavage site
mutant) |
Chickens |
[41] |
Subunit |
Mice (BALB/c) |
[87,88] |
EEEV |
SINV/EEEV Chimeras |
Mice (NIH Swiss) |
[35,36] |
Attenuated and
Inactivated |
Mice (BALB/c) |
P Glass, personal
communication |
|